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Abstract
Background: Tea consumption is associated with a lower risk of cardiovascular disease including stroke. Direct effects of tea
components on the vasculature, particularly the endothelium, may partly explain this association.
Objective: We performed a meta-analysis of controlled human intervention studies on the effect of tea on flow-mediated
dilation (FMD) of the brachial artery, a measurement of endothelial function, which is suggested to be associated with
cardiovascular risk.
Methods: Human intervention studies were identified by systematic search of the databases Medline, Embase, Chemical
Abstracts and Biosis through March 2009 and by hand-searching related articles. Studies were selected based on predefined
criteria: intervention with tea as the sole experimental variable, placebo-controlled design, and no missing data on FMD
outcome or its variability. A random effects model was used to calculate the pooled overall effect on FMD due to the intake
of tea. The impact of various subject and treatment characteristics was investigated in the presence of heterogeneity.
Results: In total, 9 studies from different research groups were included with 15 relevant study arms. The overall absolute
increase in FMD of tea vs. placebo was 2.6% of the arterial diameter (95% CI: 1.8-3.3%; P-value ,0.001) for a median daily
dose of 500 mL of tea (2–3 cups). This is a relative increase of approximately 40% compared to the average FMD of 6.3%
measured under placebo or baseline conditions. There was significant heterogeneity between studies (P-value ,0.001) that
might partly be explained by the cuff position either distal or proximal to the area of FMD measurement. No indication for
publication bias was found.
Conclusion: Moderate consumption of tea substantially enhances endothelial-dependent vasodilation. This may provide a
mechanistic explanation for the reduced risk of cardiovascular events and stroke observed among tea drinkers.
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Introduction
Tea consumption is associated with a reduced risk for
cardiovascular disease (CVD) including stroke [1–3]. A suggested
mechanism that may partly explain this association is the direct
effect of tea on the vasculature, particularly the endothelium [3].
The endothelium, the inner lining of all blood vessels, plays a
central role in vascular homeostasis, including maintenance of
vascular tone, balancing blood fluidity and blood clotting, and
vascular inflammatory processes [4]. Endothelial dysfunction
refers to disruption of the homeostatic endothelial condition, and
plays an important role in the development of atherosclerosis and
CVD [5]. Many CVD risk factors such as hypercholesterolemia,
diabetes, hypertension, ageing, smoking and hyperglycaemia, have
been shown to be accompanied by endothelial dysfunction [6,7].
Endothelial (dys)function can be determined by assessing the
degree of flow-mediated dilation (FMD) of the brachial artery
[8,9]. FMD represents the endothelium-dependent relaxation of
the artery, mediated via release of nitric oxide (NO), in response to
a hyperaemic stimulus (increased flow established by the release of
a supra-systolic inflated cuff around the arm), and is seen as a
direct and reliable measure of vascular reactivity of the macro
circulatory system. Although not conclusive [10–12], evidence
from prospective studies suggests that FMD is independently
inversely associated with cardiovascular events [13–18].
Several human intervention studies have investigated the effect
of tea consumption on endothelial function [19–26]. The majority
of these studies report a beneficial effect of tea on FMD. A meta-
analysis by Hooper et al. [27] on flavonoids/flavonoid-rich foods
and cardiovascular risk factors suggested a beneficial effect of black
tea on FMD of 3.40% (95%CI: 1.85–4.95%) after long-term
consumption, and 1.70% (95%CI: -0.17-3.57%) acutely after tea
intake. These data were, however, based on only 2 studies, and
several other studies on black and green tea and FMD have been
published since.
We performed a meta-analysis of currently available data from
human intervention studies on the effect of tea consumption on
endothelial function as measured by FMD of the brachial artery.
PLoS ONE | www.plosone.org 1 March 2011 | Volume 6 | Issue 3 | e16974Objectives were to estimate the size of the overall effect and to
identify the impact of various subject and treatment characteristics
on the effect of tea on FMD in the presence of heterogeneity.
Methods
The supporting PRISMA checklist for this meta-analysis is
available as supporting information; see Checklist S1.
Search strategy
Potential relevant published studies were identified from the
databases Medline, Embase, Chemical Abstracts and Biosis (from
starting date of the databases until March 2009). The following
search terms were used to search in titles and abstracts: (tea or
black tea or green tea or flavonoid? or tea extract? or tea
component? or tea solid? or camellia sinensis) and (flow-mediated
or flow mediated or FMD or endothelial function or endothelial
dysfunction or endothelium-dependent or blood flow or arterial
stiffness or vascular resistance or circulat* or micro-circulat* or
microcirculat* or vasodilat* or dilat*). The search was limited to
studies in human adults.
Selection criteria
We selected human intervention studies that investigated the
relationship between tea intake and FMD. The selection was
performed in 2 steps. The first selection step was based on titles
and abstracts. Studies were included if they met the following
inclusion criteria: human intervention study with adults (with
parallel or crossover design), intervention with tea as the only
experimental variable, outcomes related to vascular function,
endothelial function or FMD and no intentional co-intervention
from which the effect of tea could not be isolated. During the
second selection step, full texts of the papers were read to check
whether the first selection step was done correctly, and to exclude
studies based on the following criteria: missing data on FMD, no
measures of variability of FMD reported, no suitable control
treatment included in the design, and no full text available. We
focussed on studies with freshly brewed tea or with tea powder that
was produced by drying freshly brewed tea, excluding purified or
isolated substances from tea. In case of unclarity, inclusion of a
study was discussed among 2 of the authors (RTR and RD) to
reach a decision. For completeness, potential relevant and eligible
studies published after completion of the systematic search through
March 2009 were also included.
Data extraction and quality assessment
For each of the studies selected, data were extracted using a
custom-made database on identification of the study (author, year
of publication, country), study design (parallel or crossover),
subject characteristics (age, body mass index (BMI), gender,
ethnicity and health status), diet, treatment characteristics (green
or black tea, dosage of tea, duration, preparation of tea), FMD
analysis characteristics (fasted or non-fasted, position of cuff, time
of occlusion), FMD values with accompanying measures of
variance, and study quality. When data were missing, the authors
of the original study were approached to obtain these data
(successful in 2 occasions [24,28]).
Quality of the studies was assessed by to a tool that was
specifically developed for this meta-analysis based on the Delphi
Consensus [29]. The following criteria were used for scoring the
quality of each study: proper randomization procedure (quality
score =1 point), similarity of treatment groups in relevant
variables at baseline (1 point), specification of eligibility criteria
(1 point), blinding of subjects and investigators (each 1 point), valid
point estimates and measures of variability presented for FMD (1
point), and data on degree of compliance (1 point). A combined
quality score was obtained by adding the scores for each criterion.
Thus, quality score could range from 0 to 7 points. The quality
scores were used only for performing subgroup analyses to
examine whether the net response in FMD was different in
studies with high vs. low quality. Because scoring of quality is
intrinsically subjective, the quality scores were not used to exclude
lower quality studies from the meta-analysis or to weigh the
studies.
Statistical analysis
FMD is expressed as follows: FMD (%) = [(hyperaemic
diameter – resting diameter)/resting diameter] 6100 [8], where
resting diameter is the diameter of the brachial artery before any
flow stimulus in the artery is created, and hyperaemic diameter is
the diameter of the artery observed after release of the inflated
cuff. For cross-over studies, the net response in FMD was
calculated by subtracting the mean FMD value at the end of
control period from the mean FMD value at the end of the
treatment period. For parallel studies, the net response in FMD
was calculated by subtracting the mean change in FMD in the
control group from the mean change in the treatment group,
where mean change is FMD value at the end of the intervention
minus the FMD value at the start of the intervention.
For calculating the pooled overall effect of tea on FMD, we
weighed the studies by the inverse of their variance (1/SE
2) (SE =
standard error), giving more weight to more precise studies. When
not provided, the SE of the net change was derived from P-values
or calculated according to the equations by Follmann et al. [30].
For the latter, we assumed a within-subject correlation coefficient
of 0.5 [31]. Since it is unlikely that all the heterogeneity in results is
due to the treatment itself, a random effect model according to the
methods described by DerSimonian and Laird and van Houwelin-
gen et al. was used to take both within- and between-trial variance
into account [32,33]. Calculations were done using the PROC
MIXED model of the SAS analytical system (version 9.2).
The extent of heterogeneity between studies was assessed by
estimating the proportion of total variation across studies due to
variability between studies rather than due to chance, using the
Cochran’s Q statistic and the I
2 statistic [32,34,35]. The I
2-statistic
ranges between 0 and 100%; an I
2-value above 50% indicates
relevant heterogeneity [36].
To relate the size of the observed FMD responses to one or
more potential covariates, we performed weighted meta-regression
[37,38]. The pre-defined covariates were health status (healthy or
diseased), mean age, mean baseline FMD, dose of tea, type of tea
(green or black tea), type of placebo (hot water or caffeine
controlled), duration of tea (short-term/acute or long-term/
chronic (.2 weeks)) and quality. In addition, we calculated a
pooled FMD effect for different subgroups of the covariates under
investigation. For the continuous variables, subgroups were
defined based on above or below the median values. In case a
subgroup consisted of less than 5 study arms, no subgroup analysis
was performed; instead, we performed sensitivity analysis exclud-
ing those studies placed in the smallest subgroup.
To assess presence of publication bias, we visually inspected the
symmetry of a funnel plot of the net effects on FMD observed in all
studies expressed against their respective precisions (1/SE). The
degree of funnel plot asymmetry was assessed by regression
analysis of the standard normal deviate as a function of the
precision [39]. Absence of publication bias is reflected in an
intercept close to 0 with the slope of the regression line close to the
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if P-value ,0.1.
Results
Characteristics of included studies
A total of 478 potentially relevant papers were retrieved with the
systematic search. Based on the predefined selection criteria, 470
papers were excluded for different reasons (Figure 1). One eligible
study was retrieved after the search [28], yielding a total of 9
studies with 15 study arms for this meta-analysis (Table 1). Seven
studies had a crossover design [19,22–24,26,40,41] and two a
parallel design [20,28].
A total of 213 subjects participated in the 9 studies. The number
of subjects per study ranged from 14 to 50 subjects. Mean age
ranged from 30.0 to 62.1 years and BMI from 22.1 to 29.7 kg/m
2.
One study included only men [41] whereas 2 studies included only
women [23,24]; in the remaining studies, except for 1 study that
did not report gender [22], the percentage male ranged from 60%
to 93%. In 5 out of 9 studies, subjects were healthy or mildly
hypercholesterolemic; the other studies included renal transplant
recipients [40], chronic kidney disease patients [28], or coronary
artery disease patients [19,22]. Mean baseline FMD ranged from
4.3% to 7.8%.
Seven studies investigated the effect of black tea; only 3 studies
investigated (also) green tea [23,26,28]. In the majority of the
studies, tea was brewed by infusing a certain amount of tea (5–
10 g/d) in a defined amount of hot water (450–1250 mL) for a
defined time period (2–5 min); in 2 studies [28,41] tea was
prepared by dissolving a tea powder in hot water. The study by
Grassi et al. [41] used a control drink that contained an equal
amount of caffeine as the tea interventions; the remaining studies
used hot water without caffeine as control. Six studies investigated
the acute effects on FMD, 30–120 minutes after drinking the
prescribed amount of tea [19,22–24,26,40], or the acute effects
upon 1 week of daily tea consumption [41], whereas 3 studies (also)
investigated the long-term effects (4 weeks) on FMD after an
overnight fast and abstinence of tea [19,20,28]. Except for 2
studies that determined FMD with the occlusion cuff placed
proximally to the area of measurement [19,40], the majority of the
studies determined FMD with the occlusion cuff placed distally.
Only 2 studies [20,22] used a semi-automated edge-detection
system to determine the brachial artery diameter.
Heterogeneity and publication bias
Between-study heterogeneity as assessed by the Q-statistic was
significant (62.1, P-value ,0.001, with accompanying I
2 statistic
75.8%) justifying the use of a random effects model for calculating
the pooled overall effect.
Visual inspection of the funnel plot (Figure 2) did not clearly
indicate presence of publication bias. Indeed, regression analysis of
the standard normal deviate as a function of the precision did not
reveal clear funnel plot asymmetry (intercept: P-value =0.176),
indicating absence of publication bias.
Effect of tea on FMD
In each of the individual studies, except for one [22], tea showed
a statistically significant effect on FMD. In all studies combined,
consumption of tea increased FMD vs. control by 2.6% of arterial
dilation (95% CI: 1.8–3.3%; P-value ,0.001), which is a relative
improvement of approximately 40% compared to the average
FMD of 6.3% under placebo (for cross-over trials) or baseline (for
parallel trials) conditions (Figure 3). The median dose was 500 mL
tea per day, which is equivalent to 2–3 cups per day.
Covariate analysis
Of the variation in FMD responses between the studies, study
quality score explained 52%, type of placebo 20%, type of tea
17%, health status 9%, study duration 6%, age 1%, baseline FMD
1%, and dose of tea ,1%. Only the quality score of trials
significantly correlated with the net FMD responses (P-value =
0.002). However, this correlation lost significance (P-value =
0.725) when all covariates were simultaneously included in the
model. Furthermore, the study with the highest reported response
in FMD was ranked with the lowest quality score [40]. Excluding
this study from the analysis did not materially affect the overall
effect (average FMD response 2.4%, see post-hoc analyses), but
reduced the association between the quality score and the FMD
effect considerably (P-value =0.030; R
2 =0.34). This indicates
that the size of the response is less explained by the quality score
when considering the disproportional impact of this study on the
covariate analysis.
Figure 1. Flow diagram of the study selection procedure. *One study was identified after the systematic search through March 2009.
doi:10.1371/journal.pone.0016974.g001
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PLoS ONE | www.plosone.org 4 March 2011 | Volume 6 | Issue 3 | e16974Analysis of the overall FMD effect of tea within predefined
subgroups (with data from at least 5 study arms) indicated
significant overall FMD effects for subgroups with diseased and
healthy subjects, young and old subjects, high and low baseline
FMD values, different amounts of tea prescribed, different study
quality scores, black tea as intervention, when using hot water as
control, and with acute intake of tea (Table 2). Between predefined
subgroups, no significant differences in FMD responses were
found, except for study quality score with higher quality studies
showing smaller improvements in FMD (P-value =0.005).
In post hoc analyses, we checked the impact of 2 individual
studies with specific characteristics on the overall estimated effect
on FMD; we excluded the study by Grassi et al. [41] because it
had with 4 study arms a disproportionally large weight, and the
study by Ardalan et al. [40] because it included renal transplant
recipients representing a very specific population. Exclusion of
these studies did not substantially affect the outcome; the pooled
overall FMD effect estimate without the study by Grassi et al. was
3.0% (95% CI: 2.1–4.0; P-value ,0.001) and without the study by
Ardalan et al. 2.4% (95% CI: 1.7–3.0; P-value ,0.001) vs. the
2.6% (95% CI: 1.8–3.3%) in all 9 studies. Furthermore, excluding
the most extreme outlier [40] from the publication bias analysis
improved the symmetry of the funnel (intercept: P-value =0.401)
supporting the indication of absence of publication bias (Figure 2).
Also in post hoc analyses, we investigated the impact of cuff
position (either proximal or distal to the area of ultrasound
measurement) on the FMD response to tea consumption. Based on
meta-regression, cuff position was significantly correlated with the
FMD responses; smaller responses to tea were observed with distal
occlusion (P-value 0.017; R
2=0.36). Due to the limited number of
studies that used proximal occlusion, we performed sensitivity
analysis only including those studies that used distal occlusion
(n=12) and calculated a significant overall FMD effect of 2.1%
(95% CI: 1.5–2.7; P-value ,0.001).
Tea effects on endothelium-independent vasodilation
The majority of studies, except for two [40,41], assessed
endothelium-independent vasodilation by sublingual administra-
tion of nitroglycerine spray. No effect of tea was found in 6 out of 7
studies (data not shown). Only Hodgson et al. [20] reported a
small but significant enhancement of the endothelium-indepen-
dent vasodilation after black tea consumption.
Discussion
In this meta-analysis, we summarized published evidence from 9
human intervention studies that investigated the effect of tea
consumption on endothelial function as measured by FMD. It was
found that moderate consumption of tea substantially enhances
FMD. This is in line with findings from a previous meta-analysis
on flavonoids/flavonoid-rich foods and cardiovascular risk factors
[27], that included 2 studies on tea and FMD published at that
time [19,22]. The effect of tea on FMD seems robust because the
estimated overall effect is large and the effect was observed in 8 out
of 9 studies including different study populations and different tea
types. Also, we could not detect indications of systematic
publication bias.
During the last decade, FMD has been increasingly used as tool
to assess effects of therapeutic interventions on endothelial
function in humans. The relevance of FMD for predicting CVD
risk independent of other well-established risk factors is crucial in
this respect. Several prospective studies, but not all [10–12],
indicate an independent inverse association between FMD and
risk for cardiovascular events, not only in patients with varying
stages of arterial disease [13–16], but also in subjects without
diagnosis of CVD [17,18]. FMD has been shown to add to the
predictive value of ankle-brachial pressure index [14] and
hyperaemic flow velocity [42] in patients with peripheral arterial
disease. In addition, Chan et al. [16] showed an interaction
Figure 2. Funnel plot. The net FMD responses are expressed against their respective precisions (1/SE) in 15 study arms. The net responses are
scattered around the pooled overall effect of 2.6% (dotted line). In case the most extreme outlier (red circle) is excluded from the analyses, the net
responses are more symmetrically scattered around the adjusted pooled overall effect of 2.4% (red dotted line).
doi:10.1371/journal.pone.0016974.g002
The Effect of Tea on Flow-Mediated Dilation
PLoS ONE | www.plosone.org 5 March 2011 | Volume 6 | Issue 3 | e16974between carotid plaque burden and endothelial function for
predicting future adverse vascular events in coronary artery
disease patients. On the contrary, FMD does not seem to be
independently associated with CVD outcomes when intima-media
thickness is considered at the same time [11,12]. Whether
improvement in FMD in response to treatment can predict
CVD risk was assessed in at least 2 studies. The study by Kitta
et al. [43] suggested that optimized therapy to reduce risk factors
for coronary artery disease is effective in improving FMD in CVD
patients, with persistent impairment in FMD being an indepen-
dent predictor of events. Modena et al. [44] showed that in
postmenopausal women, antihypertensive therapy positively
affects FMD, and that improvement in FMD identified patients
with a subsequent more favourable prognosis for events when
adjusted for changes in other risk factors such as SBP and DBP.
Thus, taken together, an independent association is suggested
between FMD and CVD risk, although causality remains to be
proven.
Potential health properties of tea are likely due to certain
chemical substances extracted from the tea leaves. The active tea
substances responsible for the increase in FMD are still unknown,
but a specific role for certain flavonoids, such as the catechins
epicatechin, epigallocatechin, epigallocatechin gallate, and epica-
techin gallate has been suggested [45]. The caffeine in tea
probably does not contribute to the effect; an oral dose of pure
caffeine was found to not significantly affect FMD [19] or even
reduced FMD [46]. Also, tea solids dose-dependently affect FMD
when caffeine intake is kept constant [41]. In one study [22], tea
did not significantly improve FMD. An explanation may be found
in the fact that FMD was measured only shortly (60–90 min) after
tea consumption. Since catechin plasma concentrations peak 1–
2 h after intake in fasted state and 2–3 h in postprandial state
[47,48], it may be that the catechins were not yet fully absorbed at
the time of the FMD assessment. However, whether the catechins
are the true actives remains to be elucidated.
With the studies included in our analysis, we were not able to
confirm a dose-response relation between amount of tea consumed
and FMD response as was suggested by the study by Grassi et al.
[41]. The absence of a clear dose-response relation may be due to
the inaccuracy of expressing tea intake as volume of beverage
consumed per day rather than as amount of potentially active
substances ingested in the different tea interventions. The included
studies used different tea products and preparation methods with
varying amounts of tea leaves, brewing time, and water
temperatures. These differences presumably result in different
concentrations of active substances per tea serving [49]. It has
Figure 3. Forest plot. The net FMD responses and 95% confidence intervals of 15 study arms from 9 studies investigating the effect of tea on FMD
are shown. The dotted line indicates the pooled overall FMD effect (2.6%), in which each study arm was weighed by the inverse of its variance (1/SE
2).
In case of multiple study arms, the intervention is specified between brackets.
doi:10.1371/journal.pone.0016974.g003
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content in tea is flavonoids [50]. Black tea contains on average
992 mg/L of total polyphenols, whereas green tea contains
591 mg/L [49]. A dose of 500 mL of tea (,2–3 cups) can thus
be estimated to contain on average 415 mg of flavonoids for black
tea and 248 mg for green tea. However, these are rough estimates
and, in practice, the variation between tea brews will be large.
A proposed mechanism by which dietary flavonoids could affect
FMD is that they improve the bioactivity of the endothelium-
derived vasodilator NO [51] by enhancing NO synthesis or by
decreasing superoxide-mediated NO breakdown [52]. Flavonoids
may increase endothelial NO production [53,54] by stimulating
Akt-mediated endothelial-derived NO synthase activity [55,56],
and additionally decrease levels of the vasoconstrictor endothelin-1
[53]. Another mechanistic explanation is that methylated
flavonoids inhibit nicotinamide adenine dinucleotide phosphate
oxidase activity, and thereby reduce the generation of reactive
superoxide and hydroxyperoxide [57]. However, the precise
mechanism is not yet fully revealed, and different potentially
active flavonoids and their metabolites may have different effects.
No indication of endothelial-independent vasodilatory effects of
tea was found in the included studies. Although not conclusive, this
makes it unlikely that consumption of tea sensitizes arterial smooth
muscle cells for NO.
Because heterogeneity between studies was significant, we
analyzed the impact of potential covariates on the relationship
between tea and FMD in order to identify factors that could
explain differences in findings between studies. Only the study
quality score was significantly associated with the size of the FMD
response observed after tea consumption, with higher quality
studies showing smaller improvements in FMD than the lower
quality studies. However, this association was no longer significant
when corrected for other covariates in the same model. It should
be noted that scoring the quality of a study is intrinsically
subjective. Thus, the apparent relation between study quality and
observed effect on FMD should be interpreted with caution.
Overall, the number of studies included in this meta-analysis was
too limited to allow a thorough, reliable analysis of sources of
heterogeneity.
Our study has other limitations. Firstly, reproducibility of a
functional marker such as FMD is low as compared to most
biochemical markers. Standardized protocols for imaging tech-
niques, as for example recently described by Thijsen et al. [58], are
required to reduce within-subject variability. These should include
multiple measurements and duplicate readings, preferably using
automated vessel wall boundary detection devices [59,60]. Such
an automated device was used in only 2 out of 9 studies included in
the present meta-analysis. Also, the position of the occlusion cuff,
either proximal or distal to the area of FMD measurement, is
important to consider. A post-hoc analysis suggested that cuff
position has an impact on the size of the FMD response after tea
consumption, with larger effects on FMD when using the proximal
occlusion method, which may explain part of the heterogeneity
found between the studies. Doshi et al. [61] have shown that FMD
assessed by the distal occlusion method can be abolished by
infusion of the NO synthase inhibitor NG-monomethyl-L-
Table 2. Effect of tea on FMD within and between different subgroups.
Trial characteristic Stratification variable
a No of study arms Pooled FMD effect (%) 95% CI P-value
Subgroup analysis
Health status Diseased 6 3.1 (2.1; 4.2) ,0.001
Healthy 9 2.3 (1.5; 3.0) ,0.001
D 15 0.9 (20.4; 2.2) 0.188
Baseline FMD ,6.4% 7 2.6 (1.6; 3.7) ,0.001
$6.4% 8 2.5 (1.7; 3.4) ,0.001
D 15 0.1 (21.2; 1.5) 0.866
Age ,55 yr 6 2.4 (1.4; 3.4) ,0.001
$55 yr 9 2.7 (1.8; 3.6) ,0.001
D 15 20.3 (21.6; 1.1) 0.702
Dose #500 mL 10 2.9 (2.0; 3.7) ,0.001
.500 mL 5 2.0 (0.9; 3.2) ,0.001
D 15 0.8 (20.6; 2.2) 0.259
Quality Low quality (,6 points) 6 3.7 (2.7; 4.7) ,0.001
High quality ($6 points) 9 2.0 (1.4; 2.7) ,0.001
D 15 1.7 (0.5; 2.9) 0.005
Sensitivity analysis
b
Type of tea Black tea 12 2.3 (1.5; 3.1) ,0.001
Type of placebo Water 11 3.0 (2.1; 4.0) ,0.001
Duration
c Short-term 8 3.0 (1.5; 4.4) 0.002
Cuff placement
d Distal 12 2.1 (1.5; 2.7) ,0.001
aFor continuous variables, studies were divided in subgroups based on their medians: 6.4% for baseline FMD, 55 years for age, 500 mL for dose of tea, and 6.0 points for
quality.
bFor type of tea, type of placebo, study duration, and cuff placement, we performed sensitivity analysis due to limited number of studies (,5) in one of the subgroups.
cFor the subgroup with short-term duration, we excluded the long-term study arms (.2 weeks) and the study arms that investigated acute upon longer-term effects.
dPost-hoc analysis.
doi:10.1371/journal.pone.0016974.t002
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PLoS ONE | www.plosone.org 7 March 2011 | Volume 6 | Issue 3 | e16974arginine, but is only partly inhibited (by ,35%) when using the
proximal occlusion method. This indicates that dilation after
proximal occlusion is not entirely NO-mediated. Because an
enhanced tea effect on FMD was found with the proximal cuff
placement, it may be speculated that tea affects the vasodilatory
response beyond affecting NO bioavailability via mechanisms still
to be revealed [58,62]. A second limitation of our analysis is that
the majority of included studies measured FMD acutely, i.e. about
2 hours after ingestion of a defined dose of tea. Although an
improvement in FMD by tea was also seen after longer-term (4
weeks) regular tea consumption, the clinical relevance of acute
improvements in FMD is unclear. Thirdly, this meta-analysis
included 2 studies that compared more than 1 active treatment to
the same control treatment [23,41]. Although bias due to multiple
inclusion of the same control group can not be excluded, we
considered this as the best possible approach to not exclude
valuable data from treatment arms (i.e. different doses). Excluding
the study that contributed most to the overall estimate with 4
treatment arms vs. the same control group [41] did not materially
affect the results.
In conclusion, our findings indicate that tea consumption results
in substantial effects on the vascular endothelium as indicated by
an improved endothelial-dependent vasodilation in the first hours
after intake, and also after longer-term regular consumption of tea.
This effect may partly explain the relationship between tea
consumption and reduced CVD risk in population studies when
assuming that FMD offers independent predictive value for CVD
endpoints. However, to what extent tea-mediated improvement in
endothelial function is indeed causally related to a reduction in
cardiovascular events can only be determined by large, long-term
randomized trials on clinical endpoints.
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